首頁 › 多發性骨髓瘤 › 加州 › Sacramento
Sacramento, CA 的 多發性骨髓瘤 臨床試驗
8 項針對 多發性骨髓瘤 的研究正在 Sacramento（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
招募中3 期
- Research Site, Sacramento
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
招募中2 期
- Kaiser Permanente - Sacramento Medical Center, Sacramento
- Sutter Sacramento, Sacramento
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
招募中觀察性研究
- University of California Davis Comprehensive Cancer Center, Sacramento
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
招募中3 期
- University of California Davis (UC Davis) Comprehensive Cancer Center, Sacramento
- University of California, Sacramento
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
招募中3 期
- Mercy Cancer Center - Sacramento, Sacramento
- Woodland Memorial Hospital, Woodland · 距離 16 英里
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
招募中1 期
- UC Davis Comprehensive Cancer Center, Sacramento
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
招募中3 期
- Mercy Cancer Center - Sacramento, Sacramento
- University of California Davis Comprehensive Cancer Center, Sacramento
- Woodland Memorial Hospital, Woodland · 距離 16 英里
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
招募中3 期
- University of California-Davis Cancer Center, Sacramento
其他城市的 多發性骨髓瘤 試驗
- New York City, NY60 項研究
- Boston, MA42 項研究
- Atlanta, GA42 項研究
- Houston, TX38 項研究
- Durham, NC37 項研究
- Nashville, TN32 項研究
- Denver, CO27 項研究
- St. Louis, MO24 項研究
- Rochester, MN24 項研究
- Columbus, OH24 項研究
- Baldwin Park, CA23 項研究
- Edison, NJ22 項研究
Sacramento 的其他研究
- 非小細胞肺癌29 項研究
- 肺癌22 項研究
- 乳癌20 項研究
- 前列腺癌19 項研究
- 轉移性癌症16 項研究
- 急性髓系白血病12 項研究
- 心臟衰竭12 項研究
- 胰臟癌12 項研究
- 癌症（所有類型）11 項研究
- 結腸癌11 項研究
- 膀胱癌10 項研究
- 大腸直腸癌10 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。